Rita Facchetti Selected Research

Rita Facchetti Research Topics

Disease

18	Hypertension (High Blood Pressure) 02/2024 - 03/2007
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2023 - 01/2007
7	Atherosclerosis 10/2022 - 09/2009
4	Obesity 10/2023 - 07/2015
4	Heart Failure 09/2023 - 10/2013
4	White Coat Hypertension 10/2022 - 12/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 03/2007
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2017 - 08/2008
3	Hyperuricemia 09/2023 - 01/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 12/2014
3	Fibrosis (Cirrhosis) 12/2018 - 01/2016
3	Diabetes Mellitus 01/2018 - 08/2008
3	Masked Hypertension 07/2015 - 08/2009
2	Hypertrophy 11/2022 - 01/2021
2	COVID-19 01/2022 - 10/2021
2	Carotid Artery Diseases 01/2019 - 07/2012
2	Hepatocellular Carcinoma (Hepatoma) 12/2018 - 10/2018
2	Liver Diseases (Liver Disease) 10/2018 - 01/2016
2	Hemochromatosis (Bronze Diabetes) 03/2016 - 08/2008
2	Iron Overload 03/2016 - 08/2008
2	Essential Hypertension 07/2015 - 11/2008
2	HIV Infections (HIV Infection) 12/2013 - 12/2010
2	Abdominal Obesity 12/2011 - 05/2010
1	Kidney Diseases (Kidney Disease) 09/2023
1	Acute Coronary Syndrome 09/2023
1	Stroke (Strokes) 09/2023
1	Sleep Wake Disorders 11/2022
1	Fever (Fevers) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2020
1	Prehypertension 01/2019
1	Infections 10/2018
1	Hepatitis B 10/2018
1	Neoplasms (Cancer) 02/2016
1	Chronic Hepatitis C 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2013
1	Body Weight (Weight, Body) 12/2011
1	Occupational Stress 05/2011
1	Obstructive Sleep Apnea 06/2010
1	Hypercholesterolemia 06/2005

Drug/Important Bio-Agent (IBA)

14	Antihypertensive Agents (Antihypertensives)IBA 02/2024 - 08/2009
13	CholesterolIBA 11/2022 - 06/2005
10	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2007
9	Blood Glucose (Blood Sugar)IBA 01/2021 - 06/2005
7	Uric Acid (Urate)IBA 09/2023 - 06/2014
7	lacidipineIBA 10/2022 - 09/2009
5	Triglycerides (Triacylglycerol)IBA 10/2023 - 05/2010
5	CalciumIBA 01/2022 - 06/2012
4	LipidsIBA 01/2023 - 12/2013
4	CreatinineIBA 11/2022 - 01/2019
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020 - 11/2008
4	Atenolol (Tenormin)FDA LinkGeneric 01/2020 - 06/2012
3	Antiviral Agents (Antivirals)IBA 12/2018 - 01/2016
2	DiureticsIBA 10/2023 - 01/2021
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2022 - 12/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 11/2008
2	IronIBA 03/2016 - 08/2008
2	Hypoglycemic Agents (Hypoglycemics)IBA 08/2009 - 06/2005
1	Coffee FDA Link 02/2024
1	ElementsIBA 09/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 10/2022
1	Digoxin (Digitek)FDA LinkGeneric 01/2022
1	IvabradineIBA 01/2022
1	Telmisartan (Micardis)FDA Link 10/2020
1	Ramipril (Altace)FDA LinkGeneric 10/2020
1	LDL CholesterolIBA 01/2017
1	Annexin A5IBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2016
1	Cytidine Triphosphate (CTP)IBA 01/2016
1	Endothelin-2IBA 05/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2010
1	Acetylcholine (Acetylcholine Chloride)FDA Link 08/2010
1	HDL CholesterolIBA 06/2010
1	HDL LipoproteinsIBA 05/2010
1	mahuang-tangIBA 08/2009
1	Transferrin (beta 2 Transferrin)IBA 08/2008

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2016
4	Liver Transplantation 10/2021 - 01/2016
1	Highly Active Antiretroviral Therapy (HAART) 12/2013
1	Glycemic Control 12/2013